Skip to main content
MP&GA Autoimmunity Research Program: two researchers reviewing fluorescence microscopy images on a laboratory monitor.
15.09.2026

Turn Your Autoimmunity Research Idea into Scientific Impact with MP&GA

The MP&GA Autoimmunity Research Program invites laboratory directors, researchers, clinicians, and scientific partners to propose studies involving products from the MP&GA autoimmune diagnostics portfolio. Do you have a promising research idea in autoimmune diagnostics? Medipan GmbH and GA Generic Assays GmbH want to help you transform it into scientific evidence that can be presented at an international congress or published in a peer-reviewed journal.

Bring your study concept to life with the MP&GA Autoimmunity Research Program

Access to suitable diagnostic kits can be a practical barrier to turning promising research ideas into scientific studies. Through the MP&GA Autoimmunity Research Program, selected projects may receive the required MP&GA assay kits together with review support for the resulting scientific work.

Proposals may include:

  • prospective or retrospective studies;
  • method-comparison and concordance studies;
  • analytical or clinical performance evaluations;
  • autoantibody and biomarker investigations;
  • studies already in progress.

We’re looking for any scientifically relevant project involving a suitable product from the MP&GA portfolio.

The portfolio includes IFA, ELISA, LINE & Dot Immunoblots, and RIA covering a broad range of systemic and organ-specific autoimmune diseases.

Take your research to Dresden in 2027

The program accepts research concepts continuously. However, projects capable of generating data for the 18th Dresden Symposium on Autoantibodies, taking place from September 7–10, 2027, are particularly encouraged.

The first-prize project will receive complimentary registration for this major international scientific event. Congress presentations are subject to abstract acceptance. Additional prizes will be awarded to other outstanding projects.

“We want to help promising study ideas develop into robust scientific evidence that can be shared with the international autoimmune diagnostics community.”

— Dr. Stefano Frasca, Head of Marketing, Medipan & GA Generic Assays

Interested? Request the complete program information

Please contact Dr. Stefano Frasca at s.frasca@medipan.de to request the complete Study Protocol template and participation conditions for the MP&GA Autoimmunity Research Program, or send a brief outline of your research idea.

Your next study could contribute valuable evidence to autoimmune diagnostics—and become a scientific publication or congress presentation.

ANCA-associated vasculitis: the 2022 ACR/EULAR classification criteria and the role of IVD antibody testing
Contact us